Rainier Group Investment Advisory’s Pfizer PFE Stock Holding History

Rainier Group Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$293K	Buy	+8,426	New	+$295K	0.12%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rainier Group Investment Advisory's PFE Position: Q3 2020 in Review

Rainier Group Investment Advisory opened a new position in Pfizer (PFE) in Q3 2020: 8,426 shares worth $293K. The stake represents 0.12% of the portfolio and ranks #47 among its holdings.

2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Rainier Group Investment Advisory held 8,426 shares of Pfizer worth $293K as of Q3 2020.
Pfizer was a new Rainier Group Investment Advisory position in Q3 2020.
Pfizer made up 0.12% of Rainier Group Investment Advisory's portfolio in Q3 2020, its #47 holding.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Rainier Group Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.